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Objectives: To characterize differences in joint pathology and pain behavior between two rat models of
osteoarthritis (OA) in order to inform selection of animal models for interventional studies.
Method: Knee OA was induced in Sprague Dawley rats by either meniscal transection (MNX) or intra-
articular injection of monosodium iodoacetate (MIA). Controls were subjected to sham surgery or
saline-injection. In a separate experiment, a single intra-articular injection of triamcinolone acetonide
was administered 14 days after MNX or MIA arthritis induction. Pain behavior and joint pathology were
quantiﬁed.
Results: Both models displayed synovial inﬂammation, chondropathy and osteophytosis. Chondropathy
scores increased with time similarly in the two models. Inﬂammation and osteophyte scores were
greater in MNX model compared to the MIA model. At day 49, the MNX model exhibited a greater
number of channels crossing the osteochondral junction compared to all other groups. The MNX model
exhibited greater weight bearing asymmetry compared to the MIA model, whereas the MIA model
displayed more consistent hindpaw allodynia. Triamcinolone attenuated weight bearing asymmetry and
distal allodynia to control levels in the MNX model, but distal allodynia was unaltered in the MIA model.
Conclusions: The comparison of the two models of OA in rats, using identical assessment tools has
demonstrated that although both models display features of OA, there are differences between the
models which may represent different aspects of human OA. Thus, model selection should be based on
the pathological aspects of OA under investigation.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The presenting symptoms of osteoarthritis (OA) are chronic pain
and disability. However, the associations between OA structural
changes andpainare oftenweak, and are incompletely understood1,2.
Current drug treatments for OA are often limited by adverse events
and incomplete efﬁcacy. Intra-articular injection of corticosteroids
and the oral or topical application of non-steroidal anti-inﬂammatory
drugs3 may be helpful for some patients. This, together with imaging
and pathological evidence, suggests an important contribution from
inﬂammation to OA pain4. Back-translation of these ﬁndings toI. Mapp, Arthritis Research UK
cknall Road, Nottingham NG5
-1757.
Mapp).
s Research Society International. Panimal models should permit the development of more speciﬁc and
effective treatments for OA.
It is currently unknown to what extent models of OA reﬂect
relationships between structure (including synovitis) and symp-
toms observed in human disease. OA models have often been
developed to explore mechanisms of cartilage damage, and reports
of synovitis and pain behavior are often limited. Furthermore, few
studies report on more than one model, and it is difﬁcult to identify
studies that make direct comparisons between models undertaken
concurrently within the same experiment, with animals random-
ized between models and assessed using identical methods. As
such, OA model selection is typically a matter of model experience
or following precedence, rather than based on the most relevant
pathophysiological phenotype for the question in hand.
We have compared structural and pain phenotypes between
two commonly used animal OA models induced by meniscal
transection (MNX) and intra-articular injection of sodiumublished by Elsevier Ltd. All rights reserved.
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section of the medial collateral ligament and subsequent full
thickness cut made through the meniscus5e7. Pathological changes
similar to post-traumatic human OA are believed to result from
instability and incongruity between joint surfaces. The mono-
sodium iodoacetate (MIA) model8e10 is induced by intra-articular
injection of the metabolic inhibitor MIA, which inhibits the
enzyme glyceraldehyde-3-phosphate dehydrogenase and disrupts
glycolysis, on which articular chondrocytes are obligately depen-
dant, leading to cell death11,12.
We monitored pain behavior by two methods. Firstly, weight
distribution, which has been shown to be reduced on the ipsilateral
hind limb1,11. Secondly, by changes in mechanical paw withdrawal
thresholds at a site distal to the injured joint, the foot pad9,13. Pain
on weight bearing, and reduced pain pressure thresholds, are both
features of human OA14. Distal reduced pain pressure thresholds
may represent abnormal central pain processing.
To investigate the contribution of inﬂammation to pain behavior
we have employed a commonly prescribed drug used in human OA,
triamcinalone acetonide, which we administered by intra-articular
injection in both models once pathological changes had become
established.
We hypothesized that the two different rat models of OA mimic
different aspects of the relationship between pain and joint struc-
ture that have been demonstrated in human OA, and aimed to
characterize any such differences in order to permit the appropriate
selection of animal models for interventional studies.Methods
Animal models
Experiments were approved by the University of Nottingham
Local Ethics Review Committee and performed under United
Kingdom Home Ofﬁce licence, using male Sprague Dawley rats of
approximately 180 g (Charles River, Kent, UK). Rats were housed on
a 12 h light/dark cycle with food andwater ad libitum. Joint swelling
was measured with digital electronic calipers (Mitutoyo, UK), with
values representing difference in knee diameters (mm) between
the experimental (left) and contralateral (right) knee joints.Study design
84 rats were randomly assigned to the following groups:
MNX, Sham surgery, MIA and intra-articular injection of saline
and eight animals per group (n ¼ 4 for saline) were sacriﬁced for
the investigation of pathological changes at 14, 35 and 49 days
after model induction. In a separate experiment, rats received a
single intra-articular injection of triamcinalone acetonide Kena-
log 40, 1 mg/25 ml (E.R Squibb & Sons Ltd, Uxbridge, UK) or
vehicle control, 14 days after model induction. 48 rats (n ¼ 8 in
each group) were randomly assigned to the following: MIA/
vehicle, MIA/triamcinalone acetonide, saline/triamcinalone ace-
tonide, MNX/vehicle, MNX/triamcinalone acetonide and Sham/
triamcinalone acetonide. Vehicle control for the triamcinalone
acetonide injection comprised of 10 ml sterile 0.9% saline con-
taining 0.075 g sodium carboxymethyl cellulose, 90 ml benzoyl
peroxide and 4 ml Tween 80 (all Sigma UK). In each experiment,
rats from all experimental groups were from a single batch of rats
and studied concurrently by the same observers blinded to
experimental group. Each experimental measurement, e.g.,
weight bearing or paw withdrawal threshold, was made by the
same observer in both models. Rats were sacriﬁced at 21 days
after model induction.Induction of MNX model
The MNX model of arthritis was induced as previously
described5. Rats were anaesthetized using 2.5% Isoﬂurane (Abbott,
Maidenhead, UK) in oxygen with a ﬂow rate of 1 L per minute. The
left leg was shaved and surgically prepared. The medial collateral
ligament was exposed and a section of it was removed to expose
themeniscus. Themeniscus was cut through its full thickness at the
narrowest point. The connective tissue layer and skin were closed
with coated Vicryl 8-0 and 4-0 sutures, respectively (Ethicon, Liv-
ingstone, UK). No post-operative analgesic drug was administered
as pain behavior was an outcomemeasure of the experiment. Sham
operated animals underwent an identical procedure with the
exception that the meniscus was not transected.
Induction of MIA model
The MIA model of arthritis was induced as previously
described5,15. Rats received a single intra-articular injection of
monosodium iodoacetate (1 mg in 50 ml sterile saline, Sigma UK)
through the infra-patella ligament of the left knee. Control rats
received intra-articular injection of saline (50 ml).
Triamcinalone acetonide intervention study
OA pathology and pain behavior were allowed to develop for a
period of 14 days after model induction, a time point at which the
pathological features of inﬂammation, chondropathy and osteo-
phyte formation are established. A single injection of 1 mg tri-
amcinalone acetonide was then given into the left knee, the
equivalent dose in mg/kg as that used in human treatment.
Baseline behavioral pain measurements were made prior to
model induction and then at day 7, 14 (prior to steroid injection), 15,
and 21 days. Animals were sacriﬁced 21 days after arthritis induction
(7 days after intra-articular triamcinalone acetonide administration).
In both studies, the animals were sacriﬁced by exposure to a
slowly rising concentration of carbon dioxide.
Histology
For each rat, skin was removed and the tibiofemoral joints were
isolated by cutting mid-femur and tibia. The intact joints were pre-
served in neutral buffered formalin (containing 4% formaldehyde) for
48e72 h and subsequently decalciﬁed in neutral buffered formalin
containing 10% formic acid for approximately 10 days. Each joint was
split by frontal sectioning and embedded to give an anterior and
posterior block. Coronal sections (5 mm), were taken through each of
the wax blocks and stained with either hematoxylin and eosin, or
safranin O. Sections were selected to give an approximate spacing of
200 mm as recommended by the OARSI histopathology initiative16.
For the triamcinalone acetonide interventional experiment, the
synovium was removed prior to ﬁxation and snap frozen before
subsequent storage at 80C.
Histomorphometry and pathology scoring
The pathology scoring was performed on H/E sections with the
exception of chondropathy which was done on Safranin O stained
sections.
Osteophytosis and chondropathy were evaluated by the method
of Janusz5. Osteophytosis was scored on a scale of 0e3, follows: 0.
No osteophyte present; 1. Mild, <50 mm; 2. Moderate, 50e150 mm;
and 3. Severe,>150 mm. Chondropathy was scored on a scale of 0e5
as follows: 0. Cartilage of normal appearance; 1. Minimal ﬁbrilla-
tion, superﬁcial zone only; 2. Mild, extends to the upper middle
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deep zone but not to the tidemark; and 5. Severe, full thickness
degeneration to tidemark. Cartilage damage was estimated as the
proportion of the section of the medial tibial plateaux involved, 1/3,
2/3 or 3/3 and the cartilage score multiplied by 1, 2 or 3 respectively
to give a total chondropathy score.
Osteochondral vascular density was determined by counting the
number of blood vessels crossing the osteochondral junction in the
entire medial tibial plateau of mid-coronal sections6. An arithmetic
mean was determined for three sections from each knee. A geo-
metric mean (95% conﬁdence intervals) was then calculated for
each group of animals.
Synovial inﬂammation was scored according to the thickness of
the synovial lining layer and synovial cellularity in the medial and
lateral tibiofemoral compartment6,
0 Lining cell layer 1e2 cells thick
1 Lining cell layer 3e5 cells thick
2 Lining cell layer 6e8 cells thick and/or mild increase in cellularity.
3 Lining cell layer >9 cells thick and/or severe increase in cellularity.All measurements were made blinded to treatment group or
surgical procedure, and with sections in random order. Each
experimental measurement, histological and behavioral, was made
by the same observer in both models.
Pain behavior
Effects of treatments on weight distribution through the left
(ipsilateral) and right (contralateral) knees were assessed using an
incapacitance meter (Linton Instruments UK) as previously
described11. The change in hindpaw weight distribution was
deﬁned as the difference in the amount of weight between the right
contralateral control limb and the left ipsilateral treated limb
divided by the sum of the weight right and left limbs  100.
Hindpaw withdrawal thresholds to mechanical stimulation
were measured using calibrated von Frey monoﬁlaments using the
up down method, as previous described17.
The animals were habituated on at least two occasions before
commencement of the experiments. Baseline behavioral pain
measurements were made at day 0 prior to model induction and
then at day 14, 28, 35, and 49 days.
Statistical analysis
Statistical analyses used Statistical Package for the Social Sci-
ences v.14 (SPSS inc., Chicago, Illinois). Differences between groups
were determined using one way ANOVA followed by post hoc t-
tests with Bonferroni’s corrections on parametric (normally
distributed) data. Tests for normal distribution were made using
the KolmogroveSmirnov test. Differences between groups inwhich
the data were not parametric were determined using the Kruskale
Wallis test with post hoc ManneWhitney analysis. The data are
presented in the text as means and the degree of uncertainty as 95%
conﬁdence intervals for parametric data and medians with inter-
quartile ranges for non-parametric data. A two- tailed P value of
<0.05 was taken to indicate statistical signiﬁcance.
Graphs were constructed using Prism v 4 (GraphPad, San Diego
CA), as Mean  S.E.M.
Results
Structural changes to the joint
Both of the models of OA displayed histologic features charac-
teristic of the clinical features of the disease [Fig. 1(a) and (b)]. BothMNX rats and MIA-treated rats displayed chondrocyte degenera-
tion, loss of surface integrity of the articular cartilage, osteophytosis
and synovial hyperplasia.
Synovial inﬂammation
Intra-articular injection of MIA did not alter the knee diameter
of the injected knee compared to the contralateral knee, and there
were no signiﬁcant differences between knee diameters for the
MIA-injected and saline-injected rats at any time point. Both the
MNX-operated knee and the sham-operated knee exhibited a small
increase in knee diameter (means 0.05 (0.39e0.62) mm and 0.4
(0.28e0.52) mm respectively at day 7), compared with contralat-
eral control knees. The difference in the increase in knee diameters
between MNX and sham controls was not statistically signiﬁcant.
Diameters of MNX- and sham-operated knees returned to control
contralateral values by day 28.
For each model and at each time point, the synovial inﬂam-
mation score was greater in the arthritic model than in the
respective control [Fig. 2(A)]. The MNX model exhibited higher
synovial inﬂammation scores than did the MIA model at each time
point. Synovial inﬂammation scores did not differ signiﬁcantly over
time in either model.
Osteophytosis
At day 49, osteophyte scores [Fig. 2(B)] were greater in the MNX
model (median ¼ 2.0 (IQR ¼ 1.0e2.0)) than sham controls
(median ¼ 0.0 (IQR 0e0), P < 0.01), and greater in the MIA model
(median ¼ 0.0 (IQR 0e2.5)) than in saline-injected controls
(median ¼ 0.0 (IQR 0e0) P < 0.01). Osteophyte scores were greater
at all time points in the MNX model, compared to the MIA model.
Chondropathy
Knee joint chondropathy scores increased in both models of OA
over time [Fig. 2(C)]; scores did not differ between theMNX and the
MIA model. At day 49, the chondropathy score in the MNX model
(median ¼ 15 (IQR 10e15)) was higher than the chondropathy
score in the sham controls (median ¼ 0.0 (IQR 0e0, P < 0.01)).
Similarly, the chondropathy score for the MIA model (median ¼ 15
(IQR 0e15)) was higher than score in the saline controls
(median ¼ 0 (IQR 0e0) P < 0.01). Chondropathy scores correlated
with weight bearing decrease only in the MNX model at day 49,
Spearmans rho e 0.59, P < 0.05.
Osteochondral channels
Greater numbers of channels crossed the osteochondral junc-
tion at day 49 in the MNX model (mean ¼ 2.5 (1.1e3.9) channels/
mm) compared to sham controls (mean ¼ 1.0 (0.3e1.6)), and
compared to the MIA model (mean ¼ 1.3 (1.0e1.7)) and saline
controls (mean ¼ 0.4 (0.9 to 1.7) each P < 0.01). Whilst the
number of osteochondral channels in sham controls, MIA model
and-saline controls decreased over time, numbers of osteochondral
channels in the MNX model did not signiﬁcantly decrease over
time.
Pain behavior
In the ﬁrst experiment, greater weight bearing asymmetry was
observed in the MNXmodel than in MIA-injected animals [Fig. 3(A)
and (B)]. Weight bearing asymmetry in the MNX model increased
with time such that there was a signiﬁcant difference between
MNX and sham controls at all time points after day 28. At day 49,
Fig. 1. a. Structural pathology in the two rat models of OA. MIA-injection (A) and MNX (C) were each followed by characteristic structural features of OA in medial tibial plateaux,
whereas saline-injected (B) and Sham-operated (D) controls displayed normal morphology. Following MIA-injection (A) there was loss of chondrocytes in the articular cartilage
(thin arrows) and a small osteophyte had formed on the medial edge of the plateau (oval area). Following MNX (C) there was extensive cartilage damage and erosion of the
underlying bone (thin arrows). A large osteophyte (oval area) has formed on the medial aspect of the plateau. Synovia (thick arrows) in both models display inﬂammatory cell
inﬁltrates. Saline-injected (B) and Sham-operated (D) knees, respectively controls for panels A and C, displayed medial tibial plateaux of normal appearance with chondrocytes
throughout the depth of the cartilage. No osteophytes were seen, and synoviumwas also of normal appearance with only a thin layer of cells at the intimal surface (hollow arrows).
Representative photomicrographs of sections with median values of measured histological features, taken from rats 49 days after model-induction. Scale bars 500 mm. Hematoxylin
and eosin stain. b. jSafranin O staining for proteoglycans. Panel A showing extensive loss of proteoglycan in the cartilage in the MIA model particularly where chondrocytes are
absent (thin arrows). Panel B saline control animal shows an even distribution of proteoglycan throughout the cartilage. Panel C shows loss proteoglycan in the MNXmodel together
with disruption of the cartilage matrix (thin arrows) and inﬂammation in the synovium (thick arrows) Panel D a sham control animal shows minimal loss of proteoglycan on the
cartilage surface. Representative photomicrographs of sections with median values of measured histological features, taken from rats 49 days after model-induction. Scale bars
500 mm. Safranin O staining.
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Fig. 2. Comparison of the extent of structural pathology between MIA and MNX models of OA over time from arthritis induction. The MNX model displayed greater synovitis (A)
and osteophytosis (B) than did the MIA model. Chondropathy scores (C) were similar in the two models. In the MNX model, the normal decline in vascular breaching of the
osteochondral junction was reduced (D). Inﬂammation (A) and osteophyte (B) scores were greater in arthritic knees from the MNX model than in the MIA model at corresponding
time points (þþ) P < 0.01. In each model, inﬂammation and osteophyte scores were greater than in their respective controls (*) P < 0.05. Inﬂammation and osteophyte scores did
not differ signiﬁcantly with time in any group. Chondropathy scores (C) increased with time when comparing day 14 to day 49 (*) P < 0.05 and did not differ signiﬁcantly between
MNX and MIA models. By day 49, arthritic knees had higher chondropathy scores than did their respective controls (þþ) P < 0.01. The density of channels crossing the osteo-
chondral junction (D) decreased with time between days 14 and 49 in both saline-injected and Sham-operated rats. Similar reductions in osteochondral breaching were observed in
the MIA model (þþ) P < 0.01. In contrast there was no signiﬁcant decrease in osteochondral channels over time in the MNX animals, such that at day 49 the MNX model displayed
greater numbers of channels crossing the osteochondral junction compared to Sham-operated controls, saline-injected controls and MIA-injected animals (**) P < 0.01.
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MNX model compared to 0.2 (3.7 to 4.3)% in sham controls.
MIA-injected rats did not display weight bearing asymmetry.
Mechanical withdrawal thresholds were measured in MNX and
MIA-treated rats and their respective controls. There was a signif-
icant decrease in the hindpaw withdrawal threshold in the MIA
model, compared to saline controls over the time course of the
study [Fig. 3(C)]. Both the MNX model and the sham controls
exhibited a small decrease in hindpaw mechanical withdrawal
thresholds (signiﬁcant only at day 14, P < 0.05 compared to base-
line) [Fig. 3(D)].
Effects of intra-articular triamcinalone acetonide injection on OA
pathology and pain behavior
Synovial inﬂammation
Treatment with triamcinalone acetonide (1 mg) at day 14
[Fig. 4(A)] reduced synovial inﬂammation by day 21 in the MNX
model (median inﬂammation score ¼ 1 (IQR 1.0e1.0)) compared
with vehicle-injected,MNX arthritic animals (median inﬂammationscore ¼ 3 (IQR 2.5e3.0), P< 0.05). Synovial inﬂammation following
triamcinalone acetonide treatment in the MNX model was compa-
rable to inﬂammation in the sham-operated, steroid-injected
animals (median ¼ 1.0 (IQR 1.0e1.0)). Similarly, intra-articular
triamcinolone acetonide reduced synovial inﬂammation scores in
the MIA model (median ¼ 1.0 (IQR 1.0e1.0)) compared to the
vehicle-injected MIA arthritic animals (median¼ 3.0 (IQR 3.0e3.0),
P< 0.05). Synovitis scores in triamcinolone acetonide-injected MIA
arthritic animals remained slightly elevated compared with syno-
vitis scores in the steroid-injected, non-arthritic controls
(median ¼ 0.0 (IQR 0.0e1.0), P < 0.05).
Pain behavior
Weight bearing asymmetry was increased in the MNXmodel by
day 14, compared with sham-operated controls, and more variably
affected in the MIA model [Fig. 5(A) and (B)]. Intra-articular injec-
tion of triamcinalone acetonide on day 14 signiﬁcantly reduced
weight bearing asymmetry by day 21 in the MNX model (MNX/
steroid mean ¼ 0.22 (2.6 to 2.6)% compared to MNX/vehicle
mean ¼ 7.8 (5.6e10.0)%, P < 0.001).
Fig. 3. Comparison of two measures of pain behavior in MIA- and MNX-induced models of OA over time. MIA (A and C) and MNX (B and D) models of OAwere each associated with
signiﬁcant pain behavior as measured by either weight bearing asymmetry (A and B) or mechanical paw withdrawal thresholds to punctate stimulation (C and D). In this
experiment, signiﬁcant weight bearing asymmetry was not demonstrated in the MIA model (A) compared to saline-injected controls, whereas weight bearing asymmetry increased
with time in the MNXmodel (B) compared to Sham-operated controls (**) P < 0.01. Weight bearing asymmetry was signiﬁcantly greater in the MNXmodel than in MIA-injected rats
at days 28, 35 and 49 (þþþ) P < 0.005. Mechanical paw withdrawal thresholds to punctate stimulation were reduced in MIA-injected animals (C) compared to saline-injected
controls at all time points, (*) P < 0.05 at day 14 and 28 and (**) P < 0.01 at days 35 and 49. Saline-injected animals displayed transient reductions in mechanical paw with-
drawal thresholds which returned to baseline values by day 35. Both MNX- and Sham-operated animals (D) showed decreased mechanical paw withdrawal thresholds at day 14
compared to baseline which did not further change with time. There were no signiﬁcant differences in mechanical paw withdrawal thresholds between MNX- and Sham-operated
animals in this experiment, nor between MNX-operated and MIA-injected animals at any time point.
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in both the MNX and the MIA models by day 14, compared with
non-arthritic controls [Fig. 5(C) and (D)]. Intra-articular injection of
triamcinolone acetonide at day 14 normalized the decrease in
hindpaw withdrawal thresholds at day 21 in the MNX model
[Fig. 5(D), MNX/steroid median ¼ 12.5 (IQR 10.0e15.0) g as
compared to MNX/vehicle median ¼ 9.0 (IQR 8.0e9.0) g, P ¼ 0.01].
Intra-articular triamcinolone acetonide injection did not signiﬁ-
cantly alter hindpaw withdrawal thresholds in the MIA model
[Fig. 5(C), MIA/steroid, median ¼ 8.0 (IQR 8.0e9.0) g compared to
MIA/vehicle median ¼ 6.0 (IQR 5.0e7.0) g, P ¼ 0.93].
Discussion
We have compared and contrasted two different models of OA,
initiated in parallel and using protocols that minimized con-
founding by experimental factors other than the method of model
induction. Both MIA and MNX models of OA in the rat displayed
features that are comparable to human OA, including pain behavior,
chondropathy, osteophytosis and synovial inﬂammation. In both
models, osteophytosis and synovitis were evident at 14 days after
model induction, and chondropathy progressively increased be-
tween 14 and 49 days after induction.
Despite these similarities, we also found differences between
the two models that may indicate that they mimic different aspects
of human disease. In particular, inﬂammation and osteophyte
scores were greater in MNX- than inMIA-induced OA, and at day 49MNX-induced OA displayed greater numbers of channels crossing
the osteochondral junction compared to all other groups. Rats with
MNX-induced OA displayed greater weight bearing asymmetry
than after MIA-injection, whereas those with MIA-induced OA
displayed more consistent lowering of the mechanical withdrawal
thresholds of the hindpaw than after MNX.
We demonstrated synovial inﬂammation in both models.
Synovitis is a feature of human knee OA18, in which it contributes
to pain19 and is associated with progressive joint damage20.
Intra-articular injection of triamcinalone acetonide, an anti-
inﬂammatory glucocorticosteroid, reduces pain in patients with
knee OA, and we here conﬁrm that intra-articular glucocorticos-
teroidsmay also reduce pain behavior in rodentmodels21.We found
that synovitis was more pronounced in the MNX than the MIA-
induced model of OA. Intra-articular triamcinolone acetonide
injection had a greater effect on pain behavior in the MNX model,
consistent with a greater contribution of synovitis to pain in the
surgical model. We selected 14 days as a minimum time point at
which OA changes become established and for ethical reasons to
reduce the amount of time animals were in pain. A relative insen-
sitivity of the MIA model to the cyclo-oxygenase inhibitors cele-
coxib and diclofenac has been reported13,22, particularly at late time
points 18 days or more after model induction23.
Synovitis has been associated with cartilage damage and
osteophyte formation both in man20 and in a murine model of
arthritis24. Osteophyte growth may be stimulated by transforming
growth factor beta (TGFb), which is upregulated during synovitis25.
Fig. 4. Inﬂammation scores and synovial photomicrographs of MIA- and MNX-induced models of OA showing the effect of triamcinalone acetonide on the models seven days after
treatment. A single administration of triamcinalone acetonide (steroid) reduced the inﬂammation scores in both the MIA and MNX model 7 days after the treatment when
compared to vehicle treated controls. (P < 0.05 in both cases). Representative photomicrographs of sections with median values of measured histological features, taken from rats 21
days after model-induction. Panel B MIA vehicle-treated, panel C MIA triamcinalone acetonide-treated. Panel D MNX vehicle-treated, panel E MNX triamcinalone acetonide-treated.
Treatment reduces the overall thickness of the lining layer in both models. Scale bars 50 mm. Hematoxylin and eosin stain.
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nerves penetrate newly formed cartilage at the joint margins dur-
ing osteophyte formation26. Synovitis may therefore contribute to
OA pain both directly and by augmenting other aspects of OA
structural pathology.
Vascular breaching of the osteochondral junction also distin-
guished between the two models in the current study. Normal
adult human cartilage is avascular but in OA vascular growth occurs
at the osteochondral junction26,27. We extend our previous ﬁndingsshowing that osteochondral vascularity was higher in rats
following MNX-surgery6, now showing that it was also greater in
the MNX than MIA model. MIA-induced OA can, however, under
some circumstances, also lead to increased numbers of osteo-
chondral channels28. High osteochondral channel densities may
indicate increased new channel formation29 as they are reduced
following treatment with the osteoclast inhibitor zoledronate28.
Osteochondral channels in these immature animals displayed the
normal decrease during maturation in control and MIA-injected
Fig. 5. Effects of intra-articular triamcinalone acetonide injection on pain behaviors in the monoiodoacetate (MIA) and MNX models. Intra-articular triamcinolone acetonide in-
jections were administered in arthritic and control knees 14 days after model induction (dotted line) in the MIA- (A and C) and MNX-induced (B and D) models of OA, and effects on
weight bearing asymmetry (A and B) and paw withdrawal thresholds to punctate stimulation (C and D) were determined.Weight bearing asymmetry was inconsistently increased
by day 14 in the MIA model (A) and effects of steroid-injection did not reach statistical signiﬁcance. (B) Weight bearing asymmetry was increased in MNX-operated animals
compared to Sham-operated controls by day 14 (**) P < 0.01. Triamcinolone acetonide-injected, MNX-operated animals displayed a subsequent reduction in weight bearing
asymmetry compared with vehicle-injected, MNX-operated arthritic controls (þþ) P < 0.01 to levels that were not signiﬁcantly different from steroid-treated, Sham-operated non-
arthritic controls. (Error bars shown only above data points for clarity). Paw withdrawal thresholds were reduced 14 days after arthritis induction in both MIA (C) (þþ) P < 0.01
and MNX (D) models (þ) P < 0.05 in this experiment when compared to non-arthritic controls. Intra-articular triamcinolone acetonide injection increased paw withdrawal
thresholds in the MNX model when compared to MNX/vehicle controls (*) P < 0.01, and to levels similar to those observed in steroid-treated, Sham-operated (non-arthritic)
controls. Intra-articular triamcinolone acetonide had no signiﬁcant effect on paw withdrawal thresholds in the MIA model. At day 21, paw withdrawal thresholds were signiﬁcantly
greater in triamcinolone acetonide-injected, MNX-arthritic rats compared to steroid-injected, MIA-arthritic animals, (þþ) P < 0.01.
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densities in MNX-induced OA resulted from original channels
remaining open as well as from increased new channel formation.
Increased osteochondral channel densities may be a source of pain
by exposing subchondral nerves to abnormal stimulation30, or by
permitting sensory nerve growth into the articular cartilage26.
We used two different methods to assess pain behavior. Weight
bearing asymmetry may indicate nociceptive pain, comparable to
pain on standing in people with OA. Central sensitization, resulting
in abnormal central processing of pain signals, may additionally
contribute to weight bearing asymmetry, and is the predominant
mechanism underlying the lowering of mechanical thresholds at
sites distal to the damaged joint. We found that increases in weight
bearing asymmetry were more pronounced in the MNX model,
whereas decreases in mechanical withdrawal thresholds distal to
the joint damage better discriminated between arthritic and non-
arthritic controls in the MIA model. These data suggest that the
relative contributions of peripheral and central pain mechanisms
may differ between these two models. Indeed, we have previously
demonstrated a facilitation of spinal neuronal responses, which
correlate with changes in the mechanical withdrawal thresholds in
the hindpaw17 in the MIA model and we have demonstrated the
activation of neuroimmune cells in the spinal cord in this
model15,31. The manifestation of spinal events in the MIA model
supports the hypothesis that central sensitization contributes to
pain responses in this model. In humans quantitative sensory
testing shows lowering of pain pressure thresholds at both affected
and remote sites14 which map to the sites we see here32.Based on these structural and behavioral differences between
OA models, we hypothesized that synovitis may play a greater role
in mediating pain behavior in the MNX model than in the MIA
model. Consistent with this, intra-articular injection of triamcin-
alone acetonide, which reduced synovitis, reduced both weight
bearing asymmetry and distal allodynia in the MNX model, but not
in the MIA model. These data in particular indicate that mecha-
nisms leading to the development of central sensitization may
differ between models, and that synovitis may drive central
sensitization in the MNX model of OA.
Rat models of induced OA display several advantages and limita-
tions33. Amenability to pharmacological interventions, behavioral
and structural assessment permitsmechanistic studies thatwould be
impossible in larger mammals or man due to cost and ethical con-
siderations. However, the current study illustrates thatMIA andMNX
models do not mimic identical aspects of human disease. Previous
comparisons have often depended on data collected from different
models in separate experiments, or by different researchers. In the
MNXmodel we showed no difference in pawwithdrawal thresholds
betweenMNXandshamanimals in contrast to Fernihough et al.13 and
Bove11. However, details in the surgical procedure and method of
reporting the data, respectively, may account for such differences.
Similarly, we report no inﬂammation of the knee in the MIA model
whereas others dowhen the dose ofMIA is increased13,34. The extent
of painbehaviormaybeaffectedbymany factors, including structural
severity8 strain of rat35 or housing conditions36, each of which may
confound comparisons between models. Even in the current study
the extent of distal allodynia in the MNX model was found to vary
P.I. Mapp et al. / Osteoarthritis and Cartilage 21 (2013) 1336e13451344between experiments. Furthermore, we and others have previously
demonstrated signiﬁcantweight bearing asymmetry inMIA-injected
rats9,11. Clearly, in line with ARRIVE guidelines, it is important to
reportpositive aswell asnegativeﬁndingsand their variability sothat
it is evident how robust themodels and endpoints are. However, our
current ﬁndings demonstrate that when confounders are controlled
for by concurrent experimentation, important differences in struc-
tural pathology, pain behavior and responses to an interventionwere
demonstrated between MNX and MIA models.
The lowering of hindpaw mechanical withdrawal thresholds in
non-arthritic control rats may arise as a result of post-operative
pain produced by the surgery as the medial and posterior artic-
ular nerves may be damaged during induction, and direct neuro-
toxicity has been reported with high doses of MIA37.Furthermore
neuronal injury in the dorsal root ganglia following on from pe-
ripheral inﬂammation may also be a factor34,37,38. Clearly, nerve
damage can lead to central sensitization, a key feature of neuro-
pathic pain39 and, therefore, it is essential that appropriate controls
are employed to aid attribution of behavioral changes to OA.
Conclusion
Our data provide evidence that both MIA and MNX models in
rats resemble human OA, but that differences between the models
should be taken into account when studying speciﬁc aspects of
human disease. The models differed in important aspects of both
structural pathology and pain behavior. Inﬂammation may play a
greater role in the development of pain behavior in theMNXmodel,
although in both models non-inﬂammatory mechanisms are likely
to contribute. Judicious use of animal models should help elucidate
not only mechanisms of human disease, but also inform the
development and use of novel treatments. Treatments that relieve
pain in all models may have more generalisable applicability to
human arthritis pain, whilst those whose effects are model-speciﬁc
may make important contributions to stratiﬁed care in the future.
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